One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v126.23.811.811
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 30 |
Affiliation: Cornell University, Millennium Engineering and Integration (United States), Medical Research Associates, Orlando Health, CancerCare, Takeda (United States), Sarah Cannon, University of Southern California, Rocky Mountain Cancer Centers, Kaiser Permanente Vallejo Medical Center, Center for Clinical Studies, Florida Cancer Specialists & Research Institute, Compass Oncology, Emory University, The University of Texas Southwestern Medical CenterRandomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) with Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results from the Pyramid Trial (NCT00931918)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
